Spine BioPharma, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Employees
- 11
- Market Cap
- -
Clinical Trials
1
Active:1
Completed:0
Trial Phases
1 Phases
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 3
1 (100.0%)Moderate - Severe Degenerative Disc Disease Evaluation of the Lumbar Spine
Phase 3
Active, not recruiting
- Conditions
- Lumbar Degenerative Disc Disease
- Interventions
- Drug: SB-01 For InjectionDrug: Sham Needle
- First Posted Date
- 2022-08-26
- Last Posted Date
- 2025-06-10
- Lead Sponsor
- Spine BioPharma, Inc
- Target Recruit Count
- 400
- Registration Number
- NCT05516992
- Locations
- 🇺🇸
Central Alabama Research, Birmingham, Alabama, United States
🇺🇸Evolve Clinical Research, Phoenix, Arizona, United States
🇺🇸Neurovations Research, Napa, California, United States
News
No news found